Synairgen (LSE:SNG)

UK company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - SNG

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - SNG

  • Market Cap£308.380m
  • SymbolLSE:SNG
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINGB00B0381Z20

Company Profile

Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, LOXL2 inhibitor, and others.Synairgen PLC is a respiratory drug discovery and development company. It is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in the areas, including severe asthma, chronic obstructive pulmonary disease.

Latest SNG news

Currently there for this company. Visit our news hub for other news .

SNG Regulatory news

Currently there for this company. Visit our news hub for other news .